A new approach to the validation of tissue microarrays
- 1 April 2006
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 208 (5) , 607-614
- https://doi.org/10.1002/path.1934
Abstract
Although tissue microarrays (TMA) have been widely used for a number of years, it is still not clear how many core biopsies should be taken to determine a reliable value for percentage positivity or how much heterogeneity in marker expression influences this number. The first aim of this study was to validate the human visual semi‐quantitative scoring system for positive staining of tumour tissue with the exact values determined from computer‐generated images. The second aim was to determine the minimum number of core biopsies needed to estimate percentage positivity reliably when the immunohistochemical staining pattern is heterogeneous and scored in a non‐binary way. Tissue sections from ten colorectal cancer specimens were stained for carbonic anhydrase IX (CA IX). The staining patterns were digitized and 400 artificial computer‐generated images were generated to test the accuracy of the human scoring system. To determine the minimal number of core biopsies needed to account for tumour heterogeneity, 50 (artificial) core biopsies per section were taken from the tumoural region of the ten digitally recorded full tissue sections. Based on the semi‐quantitative scores from the 50 core biopsies per section, 2500 × n (n = 1–10 core biopsies) experimental core biopsies were then generated and scores recorded. After comparison with field‐by‐field analysis from the tumoural region of the whole tissue section, the number of core biopsies that need to be taken to minimize the influence of heterogeneity could be determined. In conclusion, visual scoring accurately estimated the percentage positivity and the percentage tumour present in a section, as judged by comparison with the artificial images. The exact number of core biopsies that has to be examined to determine tumour marker positivity using TMAs is affected by the degree of heterogeneity in the expression pattern of the protein, but for most purposes at least four is recommended. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of Proliferation Indices in Glioblastoma Multiforme by Whole Tissue Section vs Tissue MicroarrayAmerican Journal of Clinical Pathology, 2003
- Validation of Tissue Microarrays Using P53 Immunohistochemical Studies of Squamous Cell Carcinoma of the LarynxLaboratory Investigation, 2003
- Automated Acquisition of Stained Tissue Microarrays for High-Throughput Evaluation of Molecular TargetsThe Journal of Molecular Diagnostics, 2003
- Validation of tissue array technology in head and neck squamous cell carcinomaHead & Neck, 2003
- Apoptotic Rate in Peripheral T-Cell LymphomasAmerican Journal of Clinical Pathology, 2002
- Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical EndpointsThe American Journal of Pathology, 2001
- Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic TumorsPublished by Elsevier ,2001
- Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human CancerThe American Journal of Pathology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- A novel quasi-viral agent, MaTu, is a two-component systemVirology, 1992